USANA Health Sciences, Inc. (NYSE:USNA) Director Sells $21,294.00 in Stock

USANA Health Sciences, Inc. (NYSE:USNAGet Rating) Director Gilbert A. Fuller sold 312 shares of the firm’s stock in a transaction dated Friday, May 20th. The shares were sold at an average price of $68.25, for a total value of $21,294.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink.

Shares of NYSE USNA traded down $0.66 during trading on Monday, reaching $68.68. 66,112 shares of the stock traded hands, compared to its average volume of 70,952. USANA Health Sciences, Inc. has a 52-week low of $67.82 and a 52-week high of $107.85. The stock has a market capitalization of $1.32 billion, a P/E ratio of 12.70 and a beta of 0.84. The company has a 50-day moving average of $77.56 and a 200-day moving average of $89.87.

USANA Health Sciences (NYSE:USNAGet Rating) last posted its quarterly earnings data on Tuesday, April 26th. The company reported $1.15 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.14 by $0.01. USANA Health Sciences had a return on equity of 27.04% and a net margin of 9.41%. The firm had revenue of $272.87 million during the quarter, compared to analysts’ expectations of $270.80 million. During the same period in the prior year, the business earned $1.45 EPS. Equities analysts anticipate that USANA Health Sciences, Inc. will post 5.28 earnings per share for the current year.

A number of hedge funds have recently modified their holdings of USNA. Vanguard Group Inc. lifted its holdings in USANA Health Sciences by 0.8% in the 1st quarter. Vanguard Group Inc. now owns 1,510,852 shares of the company’s stock worth $120,037,000 after buying an additional 12,121 shares during the period. Pzena Investment Management LLC raised its position in shares of USANA Health Sciences by 64.7% in the 1st quarter. Pzena Investment Management LLC now owns 733,939 shares of the company’s stock worth $58,311,000 after acquiring an additional 288,307 shares in the last quarter. Dimensional Fund Advisors LP raised its position in shares of USANA Health Sciences by 0.4% in the 1st quarter. Dimensional Fund Advisors LP now owns 566,420 shares of the company’s stock worth $45,002,000 after acquiring an additional 2,390 shares in the last quarter. State Street Corp raised its position in shares of USANA Health Sciences by 1.8% in the 1st quarter. State Street Corp now owns 386,877 shares of the company’s stock worth $30,737,000 after acquiring an additional 6,817 shares in the last quarter. Finally, Invesco Ltd. raised its position in shares of USANA Health Sciences by 3.0% in the 1st quarter. Invesco Ltd. now owns 159,705 shares of the company’s stock worth $12,688,000 after acquiring an additional 4,604 shares in the last quarter. Institutional investors own 55.72% of the company’s stock.

A number of equities analysts have recently issued reports on USNA shares. StockNews.com downgraded USANA Health Sciences from a “strong-buy” rating to a “buy” rating in a research report on Tuesday, April 26th. TheStreet downgraded USANA Health Sciences from a “b” rating to a “c+” rating in a research report on Wednesday, February 9th. Zacks Investment Research upgraded USANA Health Sciences from a “sell” rating to a “hold” rating in a research report on Saturday, May 14th. Finally, DA Davidson lowered their price objective on USANA Health Sciences from $86.00 to $76.00 in a research report on Wednesday, April 27th. Two investment analysts have rated the stock with a hold rating and two have issued a buy rating to the stock. According to MarketBeat, USANA Health Sciences presently has a consensus rating of “Buy” and an average target price of $105.00.

About USANA Health Sciences (Get Rating)

USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional and personal care products. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers comprising targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and foods that include meal replacement shakes, snack bars, and other related products.

Featured Articles

Insider Buying and Selling by Quarter for USANA Health Sciences (NYSE:USNA)

Receive News & Ratings for USANA Health Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for USANA Health Sciences and related companies with MarketBeat.com's FREE daily email newsletter.